Distinct mono- and dinucleotide-specific P2Y receptors in A549 lung epithelial cells: Different control of arachidonic acid release and nitric oxide synthase expression

European Journal of Pharmacology

Volumn 543, Issue 1-3, 2006, Pages 1-7

  Laubinger, Werner ^a   Tulapurkar, Mohan E ^a   Schäfer, Rainer ^a   Reiser, Georg ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

A549 cell; Arachidonic acid; Ca2+ mobilization; Diadenosine polyphosphate; iNOS (inducible nitric oxide synthase)

Indexed keywords

ADENOSINE TRIPHOSPHATE; ARACHIDONIC ACID; CALCIUM ION; CIBACRON BLUE F3GA; DIADENOSINE POLYPHOSPHATE; DIADENOSINE TETRAPHOSPHATE; DINUCLEOTIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; NUCLEOTIDE; PURINE P2Y RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; SURAMIN; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CANCER CELL; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOSINE TRIPHOSPHATE; ARACHIDONIC ACID; CALCIUM; CALCIUM SIGNALING; CELL LINE, TUMOR; CYTOSOL; DINUCLEOSIDE PHOSPHATES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; EPITHELIAL CELLS; HUMANS; LUNG; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NUCLEOTIDES; RECEPTORS, PURINERGIC P2; SURAMIN; TIME FACTORS; TRIAZINES; URIDINE DIPHOSPHATE;

EID: 33746190589     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.06.029     Document Type: Article

References (38)

1. Arroyo P.L., Hatch-Pigott V., Mower H.F., and Cooney R.V. Mutagenicity of nitric oxide and its inhibition by antioxidants. Mutat. Res. 281 (1992) 193-202
2. Berenbaum F., Humbert L., Bereziat G., and Thirion S. Concomitant recruitment of ERK1/2 and p38 MAPK signalling pathway is required for activation of cytoplasmic phospholipase A2 via ATP in articular chondrocytes. J. Biol. Chem. 278 (2003) 13680-13687
3. Chang H.C., and Weng C.F. Cyclooxygenase-2 level and culture conditions influence NS398-induced apoptosis and caspase activation in lung cancer cells. Oncol. Rep. 8 (2001) 1321-1325
4. 2 release involved in the induction of nitric oxide synthase. Br. J. Pharmacol. 130 (2000) 777-786
5. Cinkilic O., King B.F., van der Giet M., Schluter H., Zidek W., and Burnstock G. Selective agonism of group I P2X receptors by dinucleotides dependent on a single adenine moiety. J. Pharmacol. Exp. Ther. 299 (2001) 131-136
6. Communi D., Paindavoine P., Place G.A., Parmentier M., and Boeynaems J.M. Expression of P2Y receptors in cell lines derived from the human lung. Br. J. Pharmacol. 127 (1999) 562-568
7. Fabrizi C., Silei V., Menegazzi M., Salmona M., Bugiani O., Tagliavini F., Suzuki H., and Lauro G.M. The stimulation of inducible nitric-oxide synthase by the prion protein fragment 106-126 in human microglia is tumor necrosis factor-alpha-dependent and involves p38 mitogen-activated protein kinase. J. Biol. Chem. 276 (2001) 25692-25696
8. Ganster R.W., Taylor B.S., Shao L., and Geller D.A. Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 8638-8643
9. Glanzel M., Bultmann R., Starke K., and Frahm A.W. Structure-activity relationships of novel P2-receptor antagonists structurally related to Reactive blue 2. Eur. J. Med. Chem. 40 (2005) 1262-1276
10. 2 purinoceptor in renal mesangial cells. Br. J. Pharmacol. 136 (2002) 520-529
11. Insel P.A., Ostrom R.S., Zambon A.C., Hughes R.J., Balboa M.A., Shehnaz D., Gregorian C., Torres B., Firestein B.L., Xing M., and Post S.R. P2Y receptors of MDCK cells: epithelial cell regulation by extracellular nucleotides. Clin. Exp. Pharmacol. Physiol. 28 (2001) 351-354
12. Jung Y.J., Isaacs J.S., Lee S., Trepel J., and Neckers L. IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 17 (2003) 2115-2117
13. Kleinert H., Pautz A., Linker K., and Schwarz P.M. Regulation of the expression of inducible nitric oxide synthase. Eur. J. Pharmacol. 500 (2004) 255-266
14. Kojima M., Morisaki T., Tsukahara Y., Uchiyama A., Matsunari Y., Mibu R., and Tanaka M. Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue. J. Surg. Oncol. 70 (1999) 222-229
15. 2+ release studies in bronchial epithelial cells. Biochem. Pharmacol. 61 (2001) 623-629
16. Laubinger W., Wang H., Welte T., and Reiser G. P2Y receptor specific for diadenosine tetraphosphate in lung: selective inhibition by suramin, PPADS, Ip5I, and not by MRS-2197. Eur. J. Pharmacol. 468 (2003) 9-14
17. Lieber M., Smith B., Szakal A., Nelson-Rees W., and Todaro G. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int. J. Cancer 17 (1976) 62-70
18. Lowenstein C.J., and Padalko E. iNOS (NOS2) at a glance. J. Cell. Sci. 117 (2004) 2865-2867
19. Mizumura K., Hashimoto S., Maruoka S., Gon Y., Kitamura N., Matsumoto K., Hayashi S., Shimizu K., and Horie T. Role of mitogen-activated protein kinases in influenza virus induction of prostaglandin E2 from arachidonic acid in bronchial epithelial cells. Clin. Exp. Allergy 33 (2003) 1244-1251
20. Nguyen T.T., Tran E., Ong C.K., Lee S.K., Do P.T., Huynh T.T., Nguyen T.H., Lee J.J., Tan Y., Ong C.S., and Huynh H. Kaempferol-induced growth inhibition and apoptosis in A549 lung cancer cells is mediated by activation of MEK-MAPK. J. Cell. Physiol. 197 (2003) 110-121
21. Petkova D.K., Clelland C., Ronan J., Pang L., Coulson J.M., Lewis S., and Knox A.J. Overexpression of cyclooxygenase-2 in non-small cell lung cancer. Respir. Med. 98 (2004) 164-172
22. Pintor J., Diaz-Hernandez M., Gualix J., Gomez-Villafuertes R., Hernando F., and Miras-Portugal M.T. Diadenosine polyphosphate receptors, from rat and guinea-pig brain to human nervous system. Pharmacol. Ther. 87 (2000) 103-115
23. Ralevic V., and Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 50 (1998) 413-492
24. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., and Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 7240-7244
25. Sautebin L., and Di Rosa M. Nitric oxide modulates prostacyclin biosynthesis in the lung of endotoxin-treated rats. Eur. J. Pharmacol. 262 (1994) 193-196
26. Swierkosz T.A., Mitchell J.A., Tomlinson A., Botting R.M., Warner T.D., and Vane J.R. Relationship between different isoforms of nitric oxide synthase and cyclooxygenase in various cell types. Pol. J. Pharmacol. 46 (1994) 587-592
27. Swierkosz T.A., Mitchell J.A., Warner T.D., Botting R.M., and Vane J.R. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. Br. J. Pharmacol. 114 (1995) 1335-1342
28. Tedeschi E., Menegazzi M., Yao Y., Suzuki H., Forstermann U., and Kleinert H. Green tea inhibits human inducible nitric-oxide synthase expression by down-regulating signal transducer and activator of transcription-1alpha activation. Mol. Pharmacol. 65 (2004) 111-120
29. Teixeira M., Bernard C., Ferrary E., and Butlen D. Purine and pyrimidine nucleotide-sensitive phospholipase A(2) in ampulla from frog semicircular canal. Am. J. Physiol., Regul. Integr. Comp. Physiol. 280 (2001) R519-R526
30. 2 receptors induced by novel adenosine 5′-O-(1-boranotriphosphate) derivatives. Br. J. Pharmacol. 142 (2004) 869-878
31. i-inducing protease-activated receptors (PAR-1 and PAR-2) in rat astrocytes and C6 glioma cells. Neuroscience 86 (1998) 597-609
32. Vane J.R., Mitchell J.A., Appleton I., Tomlinson A., Bishop-Bailey D., Croxtall J., and Willoughby D.A. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 2046-2050
33. Watkins D.N., Garlepp M.J., and Thompson P.J. Regulation of the inducible cyclo-oxygenase pathway in human cultured airway epithelial (A549) cells by nitric oxide. Br. J. Pharmacol. 121 (1997) 1482-1488
34. Watkins D.N., Peroni D.J., Lenzo J.C., Knight D.A., Garlepp M.J., and Thompson P.J. Expression and localization of COX-2 in human airways and cultured airway epithelial cells. Eur. Respir. J. 13 (1999) 999-1007
35. Wink D.A., Kasprzak K.S., Maragos C.M., Elespuru R.K., Misra M., Dunams T.M., Cebula T.A., Koch W.H., Andrews A.W., Allen J.S., et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254 (1991) 1001-1003
36. Xiong M., Elson G., Legarda D., and Leibovich S.J. Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am. J. Pathol. 153 (1998) 587-598
37. Yamaki T., Endoh K., Miyahara M., Nagamine I., Thi Thu Huong N., Sakurai H., Pokorny J., and Yano T. Prostaglandin E2 activates Src signaling in lung adenocarcinoma cell via EP3. Cancer Lett. 214 (2004) 115-120
38. Zhao D.M., Xue H.H., Chida K., Suda T., Oki Y., Kanai M., Uchida C., Ichiyama A., and Nakamura H. Effect of erythromycin on ATP-induced intracellular calcium response in A549 cells. Am. J. Physiol., Lung Cell. Mol. Physiol. 278 (2000) L726-L736